INACT2-G: Improving Nighttime Access to Care and Treatment; Part 2- Ghana

Sponsor
University of Florida (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05506683
Collaborator
Ghana National Ambulance Service (Other)
1,365
1
1
9
152.2

Study Details

Study Description

Brief Summary

Globally, leading causes of death among children one month to 5 years old are pneumonia, diarrheal disease and malaria which are treatable early in the disease-course with low-cost medications. However, these diseases can progress to emergencies when access to care is delayed. In response, a telemedicine and medication delivery service (TMDS) was designed to improve nighttime access to pediatric care and treatment. Over 9-months, the TMDS will be implemented in a Ghanaian community to evaluate the clinical safety and operational feasibility of implementing the service.

Condition or Disease Intervention/Treatment Phase
  • Other: MotoMeds pediatric telemedicine and medication delivery service (TMDS)
N/A

Detailed Description

Globally, leading causes of death among children one month to 5 years old are pneumonia, diarrheal disease and malaria which are treatable early in the disease-course with low-cost medications. However, these diseases can progress to emergencies when access to care is delayed. In response, a telemedicine and medication delivery service (TMDS) called MotoMeds was designed to overcome barriers to seeking care. MotoMeds targets the nighttime period when barriers to accessing care are highest. The TMDS was initially deployed in Haiti and will now be evaluated for generalizability and portability in Ghana.

The study objectives are to assess clinical safety and logistical feasibility of the TMDS. The study population is an urban resource-constrained area within Accra and the enrollment period is nine months. The workflow consists of parents/guardians calling the TMDS on their child's behalf, Emergency Medical Technicians (EMTs) referring severe cases to emergency services, EMTs performing a phone assessment for non-severe cases, and EMTs traveling to the child's household to perform an in-person exam, rapid diagnostic testing for malaria where indicated as per protocol, and to deliver protocolized medications for cases within a predefined delivery zone.

EMTs and the protocols/guidelines used are supervised by Ghanaian and US physicians.

Clinical safety and feasibility of the TMDS will be evaluated using patient and logistical metrics.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1365 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Pilot Implementation of a Nighttime Telemedicine and Medication Delivery Service to Increase Access to Pre-emergency Pediatric Care in Ghana
Anticipated Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: MotoMeds users (parent/chid participant pairs)

Other: MotoMeds pediatric telemedicine and medication delivery service (TMDS)
The intervention is use of a pediatric TMDS. Eligible children experiencing acute illness are examined over the phone by EMTs who follow a set of clinical guidelines to triage, assess, and develop treatment plans for participants. To evaluate the TMDS and as a safety measure EMTs will also examine most participants in-person a their homes following the phone exam.

Outcome Measures

Primary Outcome Measures

  1. The rate of guideline adherence at the call center. [Entire 9 month study period.]

    Establish the rates of provider adherence to the TMDS clinical guidelines while performing assessments and generating treatment plans at the call center. Points of non-adherence will include severity assessments, missed danger signs and non-indicated or missed antibiotic prescriptions.

Secondary Outcome Measures

  1. The rate of guideline adherence at the household. [Full 9 month study period]

    Establish the rates of provider adherence to the TMDS clinical guidelines while performing assessments and generating treatment plans at the household. Points of non-adherence will include severity assessments, missed danger signs and non-indicated or missed antibiotic prescriptions.

  2. Sensitivity, specificity and congruence of clinical variables [Full 9 month study period]

    Determine sensitivity and specificity of each clinical variable at the call center using the in-person exam at the household as the reference standard. Establish congruence between call center and in-person assessment in terms of severity categorization, danger signs, disease type, and treatment plans.

  3. Participant clinical status at 8-12 days [Between 8-12 days]

    Determine the clinical status of participants 8-12 days following their initial contact with the TMDS. Participant families will report the status (recovered, better, same, worse, died) to TMDS staff during a follow-up phone call.

Other Outcome Measures

  1. Evaluate logistical metrics of the workflow [Full 9 month study period]

    Logistical data on patient workflow will be collected (duration of call, time to delivery). Data will be analyzed against benchmarks set in formative research.

  2. Evaluate qualitative feedback from MotoMeds users [Full 9 month study period]

    Parent/guardian feedback will be collected on the clinical, cost and quality aspects of the TMDS. Both quantitative and qualitative data will be analyzed to identify strengths and weaknesses of the TMDS design.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Child Participant Inclusion Criteria:
  • Child ≤ 10 years

  • Has an acute medical problem

  • Provides written assent (if 10 years and receives a household visit)

Child Participant Exclusion Criteria:
  • Child > 10 years

  • Child does not have an acute medical problem

  • Medical problem involves physical trauma or mental health

  • Refusal of written assent (if 10 years and receives a household visit)

Parent/Guardian Participant Inclusion Criteria:
  • Calls MotoMeds during operating hours

  • Parent/guardian of a patient participant meeting inclusion criteria

  • Adult (18 years or older)

  • Provides written consent (household visit) or a waiver of documentation of consent (no household visit)

Parent/Guardian Participant Exclusion Criteria:
  • Age < 18 years

  • No written consent or waiver of documentation of consent

  • Corresponding child does not meet inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Ambulance Service Accra Accra Metropolitan District Ghana GA-143-8975

Sponsors and Collaborators

  • University of Florida
  • Ghana National Ambulance Service

Investigators

  • Principal Investigator: Torben K Becker, MD, PhD, University of Florida

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
University of Florida
ClinicalTrials.gov Identifier:
NCT05506683
Other Study ID Numbers:
  • IRB202201648
First Posted:
Aug 18, 2022
Last Update Posted:
Aug 18, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Florida
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2022